Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Proteomics Study of Mild Cognitive Impairment and Alzheimer's Disease — Stella

Home/Alzheimer Disease, Early Onset/

View on ClinicalTrials.gov

Recruiting

Back to Alzheimer Disease, Early Onset trials

Trial locations(1 site)

China

Guangdong Province Hospital of Tradtional Chinese Medicine, Guangzhou, Guangdong

Key details

Sponsor

Guangzhou University of Traditional Chinese Medicine

Collaborators

Guangzhou Cadre Health Management Center

Enrollment target

~650 participants

Started

June 2021

Primary completion

June 2026

Age range

55 Years and older

Last updated November 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.